Amorepacific
Amorepacific is a South Korean company established in 1945, specializing in the manufacture and distribution of personal care products and cosmetics. Its extensive product portfolio includes creams, toners, serums, cleansers, eye care, sun care, and special care items. In addition to its core offerings, the company provides skin evaluation services that assess skin dryness, pollutants, and sensitivity. Amorepacific Ventures, the corporate venture capital arm of the Amorepacific Group, focuses on investing in early and later-stage companies within the beauty and wellness, digital, and sustainability sectors, aligning these investments with strategic interests to foster innovation and growth in related fields.
Milk Makeup LLC manufactures and sells cosmetics for eyes, lips, face, skin, and nail. It also offers tattoo stamps, eyelash curlers, roll + blot products, charcoal swabs, tweezers, mirrors, hairdryers, and sleep mask + cooling gel inserts; and kits. The company’s products are available online and through stores. The company was founded in 2014 and is headquartered in New York, New York. Milk Makeup LLC operates as a subsidiary of Milk Studios, LLC.
Operator of a cosmetics company intended to give a healthy change in skin conditions. The company offers detailed information about customers' facial conditions as well as climate and environmental data on which big data is used to formulate a fresh, customized skincare product and delivered as a monthly subscription, enabling customers to manage their skincare routine.
Developer of an influencer marketing platform designed to connect social media influencers with brands. The company's platform allows users to select the creator and predict the performance before advertising as well as tracking real-time performance, enabling clients to build a compelling brand story for their campaign.
BlockOdyssey Inc., based in Daejeon, South Korea, specializes in blockchain-based distribution management systems, offering tailored solutions for various industries. The company's primary focus is on anti-counterfeiting measures, utilizing blockchain technology to enhance product authenticity and security. Additionally, it is developing systems for managing logistics and distribution histories through blockchain. BlockOdyssey has garnered investment from a leading cosmetics company in Asia and is actively collaborating with pharmaceutical companies in France, indicating its strategic positioning within the B2B sector.
Elastagen Pty Ltd., a clinical stage medical company, produces and sells products based on the human protein tropoelastin. The company offers injectable dermoaesthetic products, stretch mark products, scar revision and wound healing products, and sealant and osteoskeletal products for applications areas, including skin rejuvenation, scar remodeling, and tissue repair. It sells its products through online orders. Elastagen Pty Ltd. was founded in 2003 and is based in Eveleigh, Australia with production operations in Europe; and clinical operations in the United Kingdom. As of April 6, 2018, Elastagen Pty Ltd. operates as a subsidiary of Allergan plc.
WayWearable, a ‘beauty-appliance’ company based in Seoul, Korea, has created the first total personal skincare companion that fits in your purse. The WAY device is the size of a compact powder case, but includes an array of advanced biometric and environmental sensors that it uses to make personalized skincare recommendations through its companion app. Developed in close consultation with a dermatologist, WAY helps people make smarter skincare decisions that last a lifetime. They recently joined Sparklabs, one of Asia’s top business accelerators, to bring their unique technology product to market and have kicked off an Indiegogo campaign to fund production. Their Vision - WayWearble is dedicated to improving the lives of women, by helping them more effectively manage their skin care routine, and ultimately improve health and well-being. While WAY is a first step, the company has ambitions to continue developing innovative new products that harness advances in technology, with a particular focus on the women’s health and beauty industry. In the future WayWearable will continue to develop their solutions for making more targeted and accurate suggestions of specific products that address the unique skin concerns of women, while providing deeper, personal insights into maintaining a healthy lifestyle.
Private Equity Round in 2013
TRIA Beauty, Inc. specializes in the development and marketing of light-based medical devices designed for consumer use in skincare and beauty treatments. The company offers a range of products, including a hand-held diode laser for hair removal, a blue light device targeting acne-causing bacteria, a fractional non-ablative laser for skin rejuvenation, and an eye wrinkle correcting laser. These devices provide effective solutions that allow users to achieve professional results at home. TRIA Beauty's products are available through its e-commerce platform and various retail channels, including television and physical stores, across multiple regions, including the United States, Japan, and several European countries. Founded in 2003 and headquartered in Dublin, California, TRIA Beauty was previously known as SpectraGenics, Inc. before rebranding in 2008.
Brickell Biotech, Inc. is a clinical-stage pharmaceutical company based in Boulder, Colorado, established in 2009. The company specializes in identifying, developing, and commercializing prescription therapeutics aimed at treating debilitating skin diseases in the United States. Its lead product candidate, sofpironium bromide, is currently undergoing phase 3 clinical trials for the treatment of primary axillary hyperhidrosis. In addition to this, Brickell Biotech has a pipeline that includes potential novel therapeutics for hyperhidrosis and other common dermatological conditions. The company also has a collaboration agreement with AnGes, Inc. to develop a novel DNA vaccine candidate for COVID-19.
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women’s sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, a vaginal pH regulator for the prevention of urogenital transmission of Chlamydia trachomatis infection and Neisseria gonorrhoeae infection in women. Evofem Biosciences, Inc. is headquartered in San Diego, California.
Obalon Therapeutics, Inc. is a medical device company headquartered in Carlsbad, California, specializing in the development and commercialization of innovative devices for obesity treatment. The company is known for its Obalon Balloon System, which features a swallowable capsule containing an inflatable balloon that aids in weight loss for individuals with obesity. This system includes the Obalon Navigation System, a console that uses hardware and software to track the balloon's placement, and the Obalon Touch Inflation Dispenser, a semi-automated device for inflating the balloon after placement. Additionally, it provides a disposable canister filled with gas for inflation. Founded in 2008, Obalon has established itself as a leader in gastric balloon technology, emphasizing collaboration with clinicians to enhance treatment outcomes while prioritizing safety and performance. As of early 2020, the company operated three retail treatment centers in California.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.